By: Emily Mullin
San Francisco–based Ossium Health has carried out three transplants for cancer patients using stem cells from deceased donors' bone marrow in recent months.
Emily Mullin is a staff writer at WIRED, covering biotechnology. Her work explores themes related to medicine and healthcare, including social issues such as the coronavirus and abortion, as well as innovative technologies like AI and CRISPR. She has been featured in outlets such as Mother Jones, Canada's National Observer, and The Austin Chronicle, among others.
Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston
United States (National)
Not enough data
Emily Mullin primarily covers scientific and healthcare topics, with a focus on medical advancements, genetic editing, psychedelic therapy, male contraception, and cancer treatment. She often cites data and government announcements in her articles.
She would likely be interested in receiving pitches from experts who can provide valuable insights into the latest developments within these fields. Researchers involved in groundbreaking studies or clinical trials related to genetic editing, novel medical treatments or therapies for serious conditions such as PTSD could capture her attention.
Given the nature of her coverage attributes and themes covered, she may also find value in receiving pitches that include access to exclusive data or information obtained through official government sources regarding regulatory changes or breakthroughs within the scientific and healthcare realms.
This information evolves through artificial intelligence and human feedback. Improve this profile .